p*******2
发帖数: 56 | 1 俺前天进了[email protected]，准备捂到6月15号，赌结果。它有两个pending，一个随时给结果
，另一个要到12号或者15号。只要有一个get approved，股价就会再翻个翻，有两个
approved当然会更高了。如果都failed，股价就会又回到1毛。风险就这些，想玩的可
以适当关注，选择时机进入。
详情见下面：
1.) Nephros (OTC:NEPH): Price - $0.14, Market Cap - $5M, Revenue (ttm) - $1.
7M, Net Loss - ($5.4M)
The Nephros hemodiafiltration (HDF) system is designed to improve the
quality of life for End-Stage Renal Disease (ESRD) patients while addressing
the critical financial and clinical needs of the care provider. The Nephros
HDF system removes a range of harmful substances more effectively, and with
greater capacity, than existing ESRD treatment methods, according to the
Company.
The Nephros Dual Stage Ultra-filter (DSU) is the basis for Nephros's line of
water filtration products. The patented dual stage cold sterilization
ultrafilter has the capability to filter out bacteria and, due to its
exceptional filtration levels, filter out many viruses, parasites and
biotoxins. Sale of the DSU has begun at several major U.S. medical centers
for infection control and has been selected for further development by the U
.S. Marine Corps for purification of drinking water by soldiers in the field.
On 11/14/08, Nephros submitted a 510(k) application to the FDA for approval
of its HDF products for ESRD in the U.S. market. The application details the
Company's OLpur MD220 diafilter and OLpur H2H Hemodiafiltration module.
Following its review of the application, the FDA has requested additional
information. Nephros replied to the FDA inquiries on 3/13/09. Per FDA
guidelines, the FDA has 90 days to review the additional information
provided by the Company for an expected decision by Friday 6/12/09 or Monday
6/15/09.
On 10/7/08, Nephros filed a 510(k) application for approval to market DSU
filters to dialysis clinics for in-line purification of dialysate water.
Following its review of the application, the FDA requested additional
information, and Nephros provided a formal response to the agency on 2/24/09
. Per FDA guidelines, the FDA has 90 days to review the additional
information provided; so a decision from the agency could come as early as
Tuesday 5/26/09. |
|
